No data available
No data available
No data available
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 |
|---|---|---|
| Total Revenue | 737.50 | 559.50 |
| Total Expenses | 462.30 | 338.40 |
| Profit Before Tax | 246.80 | 219.30 |
| Profit After Tax | 181 | 164.90 |
| Operating Profit After Depreciation | 279.10 | 221.10 |
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 |
|---|---|---|
| Fixed Assets | 29.10 | 7.50 |
| Total Non Current Assets | 39.60 | 10.20 |
| Total Current Assets | 391.70 | 335.20 |
| Total Assets | 431.30 | 345.40 |
| Total Shareholder's Fund | 273 | 207.60 |
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 |
|---|---|---|
| Net Cash From Operating Activities | 439 | -0.40 |
| Net Cash Used In Investing Activities | 1.90 | - |
| Net Cash Used In Financing Activities | -115.60 | 2 |
No data available
| Particulars (in ₹ Cr.) | 2025-09 | 2025-06 | 2025-03 | 2024-12 | 2024-09 |
|---|---|---|---|---|---|
| Total Revenue | 233.90 | 220.90 | 172.60 | 170.70 | 159.90 |
| Total Expenses | 148.90 | 150.70 | 108.60 | 108.60 | 96.80 |
| Profit Before Tax | 84.10 | 78.90 | 66.80 | 62.80 | 61.20 |
| Profit After Tax | 62.90 | 60.70 | 50 | 44.30 | 45 |
| Operating Profit after Depreciation | 88 | 75.80 | 69.20 | 67.10 | 67.30 |
₹55.0/Share
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,806.90 | ₹4,33,535.84 |
| Divis Laboratories Ltd | ₹6,432.15 | ₹1,70,753.37 |
| Torrent Pharmaceuticals Ltd | ₹3,801.20 | ₹1,28,644.10 |
| Cipla Ltd | ₹1,512.10 | ₹1,22,143.09 |
| Dr Reddys Laboratories Ltd | ₹1,272.95 | ₹1,06,244.27 |
| Fund Name | AUM |
|---|---|
| Sundaram Small Cap Fund | 1.57% |
| Nippon India Pharma Fund | 1.18% |
| ICICI Pru Smallcap Fund | 1.16% |
| SBI Dividend Yield Fund | 0.96% |
| ICICI Pru P.H.D Fund | 0.83% |
Sanofi Consumer Healthcare India (SCHIL) soared 8.47% to Rs 5,052 after the company reported a strong performance for the quarter ended 30 September 2025.
13 Nov 2025, 12:21 pm
On 12 November 2025
06 Nov 2025, 05:19 pm
Sanofi Consumer Healthcare India has announced the resignation of its chief financial officer, Narahari Naidu, who is stepping down to explore new opportunities outside the organization.
13 Oct 2025, 11:13 am
Sanofi Consumer Healthcare India surged 12.56% to Rs 5385 after the company announced strong financial results for the second quarter of 2025.
05 Aug 2025, 10:45 am
On 4 August 2025
29 Jul 2025, 12:58 pm

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.